Pharmaniaga Bhd (7081) - Total Assets
Based on the latest financial reports, Pharmaniaga Bhd (7081) holds total assets worth RM2.36 Billion MYR (≈ $591.86 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Pharmaniaga Bhd operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Pharmaniaga Bhd - Total Assets Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's total assets have evolved over time, based on quarterly financial data. See latest Pharmaniaga Bhd stock price today for real-time trading data and today's change.
Pharmaniaga Bhd - Asset Composition Analysis
Current Asset Composition (December 2025)
Pharmaniaga Bhd's total assets of RM2.36 Billion consist of 65.2% current assets and 34.8% non-current assets. Explore working capital position of Pharmaniaga Bhd to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 4.9% |
| Accounts Receivable | RM446.69 Million | 19.9% |
| Inventory | RM729.82 Million | 32.5% |
| Property, Plant & Equipment | RM602.78 Million | 26.8% |
| Intangible Assets | RM74.62 Million | 3.3% |
| Goodwill | RM77.03 Million | 3.4% |
Asset Composition Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pharmaniaga Bhd's current assets represent 65.2% of total assets in 2025, an increase from 59.1% in 2012.
- Cash Position: Cash and equivalents constituted 4.9% of total assets in 2025, up from 2.9% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, unchanged from 6.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 32.5% of total assets.
Pharmaniaga Bhd Competitors by Total Assets
Key competitors of Pharmaniaga Bhd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Limited
F:S5YA
|
Germany | €1.83 Billion |
|
China National Accord Medicines Corp Ltd
SHE:000028
|
China | CN¥50.56 Billion |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Ilex Medical
TA:ILX
|
Israel | ILA955.92 Million |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
Pharmaniaga Bhd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.92 | 0.65 | 0.93 |
| Quick Ratio | 0.53 | 0.37 | 0.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RM-140.86 Million | RM-746.65 Million | RM-140.72 Million |
Pharmaniaga Bhd - Advanced Valuation Insights
This section examines the relationship between Pharmaniaga Bhd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.30 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 12.8% |
| Total Assets | RM2.25 Billion |
| Market Capitalization | $294.68 Million USD |
Valuation Analysis
Below Book Valuation: The market values Pharmaniaga Bhd's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Pharmaniaga Bhd's assets grew by 12.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Pharmaniaga Bhd (2012–2025)
The table below shows the annual total assets of Pharmaniaga Bhd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | RM2.25 Billion ≈ $564.10 Million |
+12.78% |
| 2024-12-31 | RM1.99 Billion ≈ $500.20 Million |
+4.04% |
| 2023-12-31 | RM1.91 Billion ≈ $480.76 Million |
+3.66% |
| 2022-12-31 | RM1.85 Billion ≈ $463.79 Million |
-18.18% |
| 2021-12-31 | RM2.26 Billion ≈ $566.87 Million |
+42.89% |
| 2020-12-31 | RM1.58 Billion ≈ $396.73 Million |
-0.76% |
| 2019-12-31 | RM1.59 Billion ≈ $399.77 Million |
-16.53% |
| 2018-12-31 | RM1.91 Billion ≈ $478.97 Million |
+18.66% |
| 2017-12-31 | RM1.61 Billion ≈ $403.65 Million |
-4.48% |
| 2016-12-31 | RM1.68 Billion ≈ $422.57 Million |
+12.51% |
| 2015-12-31 | RM1.50 Billion ≈ $375.60 Million |
+20.35% |
| 2014-12-31 | RM1.24 Billion ≈ $312.08 Million |
+11.88% |
| 2013-12-31 | RM1.11 Billion ≈ $278.94 Million |
-9.16% |
| 2012-12-31 | RM1.22 Billion ≈ $307.05 Million |
-- |
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more